Leonard L. Winneroski

(<i>S</i>)-13-[(Dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16,21-dimetheno- 1<i>H</i>,13<i>H</i>-dibenzo[<i>e</i>,<i>k</i>]pyrrolo[3,4-<i>h</i>][1,4,13]oxadiazacyclohexadecene-1,3(2<i>H</i>)-dione (LY333531) and Related Analogues:  Isozyme Selective Inhibitors of Protein Kinase Cβ

Michael R. Jirousek, James R. Gillig, Cécile Gonzalez et al. · Journal of Medicinal Chemistry · 1996 · 338 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +8

The Potent BACE1 Inhibitor LY2886721 Elicits Robust Central Aβ Pharmacodynamic Responses in Mice, Dogs, and Humans

Patrick C. May, Brian A. Willis, Stephen L. Lowe et al. · Journal of Neuroscience · 2015 · 205 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

A New, Efficient Method for the Synthesis of Bisindolylmaleimides

Margaret M. Faul, Leonard L. Winneroski, Christine A. Krumrich · The Journal of Organic Chemistry · 1998 · 138 citations

Natural Sciences, Chemistry, Materials Science +7

Salt form selection and characterization of LY333531 mesylate monohydrate

Gary L. Engel, Nagy A. Farid, Margaret M. Faul et al. · International Journal of Pharmaceutics · 2000 · 106 citations

Natural Sciences, Biochemistry, Chemistry +8

Synthesis of Novel Retinoid X Receptor-Selective Retinoids

Margaret M. Faul, Andrew M. Ratz, Kevin A. Sullivan et al. · The Journal of Organic Chemistry · 2001 · 69 citations

Pharmacy, Medicinal Chemistry, Pharmacology +10